XLMM
2022-04-19

‌$Novavax(NVAX)$‌New data on COVID-19 Influenza combination vaccine and seasonal influenza vaccine to be presented at World Vaccine Congress


Novavax will provide a first look at data from its COVID-19 influenza combination vaccine and seasonal influenza vaccine trials, at the World Vaccine Congress (WVC) in Washington, DC, April 18 - 21, 2022. In addition, the latest data on its protein-based COVID-19 vaccine candidate, NVX-CoV2373, will be presented at both WVC and the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in in Lisbon, Portugal, April 23 - 26, 2022. Data from eight abstracts and presentations, including four oral presentations, will be presented across the two congresses.


NanoFlu identifies a recombinant hemagglutinin (HA) protein nanoparticle influenza vaccine candidate produced by Novavax. This investigational candidate was evaluated during a controlled phase 3 trial conducted during the 2019-2020 influenza season.


https://finance.yahoo.com/news/novavax-grows-presence-world-vaccine-141300942.html

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • EmilyMark
    2022-04-19
    EmilyMark
    I have 500 shares left and I really don't think we'll see 100$ till next year and that's a big maybe if everything works out....😬😬😬😬
    • XLMM: 
      I am having quite a bit of NVAX too.. have been dollar cost averaging...
  • Pixiu88
    2022-04-19
    Pixiu88
    Hopefully this will help its stock price to rise.
    • XLMM: 
      For the long run, i think so. We know that novavax is not a one trick pony that will be irrelevant after covid.
  • FranklinMorley
    2022-04-19
    FranklinMorley
    im speechless . I have never made such a terrible decision to be in a stock like this. I wonder when it's gonna jump like 40 bucks in a single day. Probly not for a while until it hits a low of 45.
    • XLMM: 
      I am pretty sure it is not going to do 40 in a day... unless it is like tesla... but then that is a 1k stock. I am hoping that the FDA approves it so that the upward swing starts.
  • littlesweetie
    2022-04-19
    littlesweetie
    The low PEG Ratio, which compensates the PE for growth, indicates a rather cheap valuation of the company.
  • Luiaine
    2022-04-20
    Luiaine
    buy
  • TIGR888
    2022-04-20
    TIGR888
    New low
    • XLMM: 
      Yeah... the vaccine stocks are nt doing well...
Leave a comment